市場調查報告書
商品編碼
1529727
美國電子醫療市場規模、佔有率和趨勢分析報告:按產品、最終用途和細分市場預測,2024-2030 年U.S. eHealth Market Size, Share & Trends Analysis Report By Product (Telemedicine, Health Information Systems, mHealth, ePharmacy), By End Use (Providers, Payers, Patients), And Segment Forecasts, 2024 - 2030 |
Grand View Research, Inc.的最新報告顯示,到2030年,美國電子醫療市場規模預計將達到3,766億美元,2024年至2030年的複合年成長率為17.6%。
電子醫療保健市場的推動因素包括遠端醫療和人工智慧等持續的技術進步、對醫療保健服務的需求不斷增加、由於 COVID-19 大流行而加速採用、支持性法律規範以及以患者為中心的護理模式,這是由幾個關鍵因素推動的。此外,電子處方箋由於能夠簡化藥物管理並提高病患安全性,已成為電子醫療市場的顯著驅動力。醫療保健提供者可以透過電子方式向藥房發送準確、易於閱讀的處方箋,從而減少錯誤並提高效率。
電子處方箋系統還透過為患者提供方便的處方藥物和劑量說明來促進更好的用藥依從性,最終改善醫療保健行業的健康結果並節省成本。例如,禮來公司 (Eli Lilly) 於 2024 年 1 月推出了 LillyDirect,這是一個數位平台,旨在簡化針對糖尿病、肥胖和偏頭痛等疾病的患者購買某些藥物的流程。該平台將患者與獨立的遠距醫療提供者聯繫起來,並提供疾病管理資源,提供直接獲取藥物的機會,並消除了從醫生那裡獲取處方箋的傳統步驟。此外,交換醫療資訊(HIE)透過促進互通性並確保醫療機構之間的無縫資料交換以改善護理協調,顯著推動了電子醫療市場的發展。
HIE 透過提供全面的病患記錄來提高護理的連續性,從而實現更快的診斷和更好的結果。 HIE 透過消除手動資料輸入和重複檢查來簡化流程、減少重複並提高效率。 HIE 允許患者存取和共用其健康記錄,從而賦予患者權力,並有助於更好地參與和決策。例如,2023 年 12 月,安大略省 21 家醫院和醫療機構推出了由 Oracle Health 提供支援的安大略省 eHub 健康資訊交換 (HIE)。這個創新平台可以在參與的醫療機構之間無縫、安全地共用患者資料。透過利用安大略省 eHub,這些機構可以簡化管理流程,最大限度地減少管理成本,並加強護理協調,以改善患者的醫療保健結果。
此外,政府舉措也對市場成長做出了重大貢獻。例如,2023 年 5 月,美國衛生與公眾服務部 (HHS) 宣布聯邦在遠端醫療和遠端醫療處方方面具有靈活性,以確保患者持續獲得基本護理。這些靈活性最初是在 COVID-19 公共衛生緊急情況 (PHE) 期間實施的,後來透過《2023 年綜合撥款法》延長至 2024年終。主要條款包括在全國範圍內擴大遠距遠端醫療服務的覆蓋範圍,允許患者家用中接受醫療保險覆蓋的遠端醫療就診,以及無需前往醫療機構等。此外,對於無法使用智慧型手機或電腦等影像媒體的人來說,某些醫療保險遠端醫療諮詢現在可以使用電話等純音訊技術進行。
The U.S. eHealth market size is expected to reach USD 376.6 billion by 2030, registering a CAGR of 17.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The eHealth market is driven by several key factors, including ongoing technological advancements like telemedicine and AI, increased demand for healthcare services, accelerated adoption due to the COVID-19 pandemic, supportive regulatory frameworks, a shift towards patient-centric care models, the cost-effectiveness of digital solutions, data analytics for patient health management, and improved global connectivity. Furthermore, e-prescription is a notable driver of the eHealth market due to its ability to streamline medication management and improve patient safety. It enables healthcare providers to electronically send accurate and legible prescriptions to pharmacies, reducing errors and enhancing efficiency.
E-prescription systems also facilitate better medication adherence by providing patients convenient access to their prescribed medications and dosage instructions, ultimately leading to improved health outcomes and cost savings in the healthcare industry. For instance, in January 2024, Eli Lilly introduced LillyDirect, a digital platform designed to streamline purchasing specific medications for patients with prescriptions addressing conditions like diabetes, obesity, and migraine. This platform offers direct access to medicines by linking patients with independent Telehealth providers and providing resources for disease management, eliminating the traditional steps of obtaining a prescription from a physician. In addition, Health Information Exchange (HIE) significantly boosts the eHealth market by promoting interoperability and ensuring seamless data exchange among healthcare entities for improved care coordination.
HIE enhances care continuity by providing comprehensive patient records, leading to faster diagnoses and better outcomes. It streamlines processes, reduces redundancies, and improves efficiency by eliminating manual data entry and repeated tests. HIE empowers patients by allowing them to access and share their health records, contributing to better engagement and decision-making. For instance, in December 2023, a group comprising 21 Ontario hospitals and healthcare facilities launched the Ontario eHub Health Information Exchange (HIE) powered by Oracle Health. This innovative platform enables seamless and secure sharing of patient data among participating healthcare organizations. By leveraging the Ontario eHub, these entities can streamline administrative processes, minimize overhead costs, and enhance care coordination to improve patient healthcare outcomes.
Moreover, the government's initiatives significantly contributed to market growth. For instance, in May 2023, the U.S. Department of Health and Human Services (HHS) announced federal flexibilities regarding telehealth and telemedicine prescriptions to ensure ongoing access to essential care for patients. Initially implemented during the COVID-19 Public Health Emergency (PHE), these flexibilities were extended through the end of 2024 via the Consolidated Appropriations Act of 2023. Key provisions include expanded access to telehealth services nationwide, allowing patients to receive Medicare-covered telehealth visits from their homes, and eliminating the need for travel to healthcare facilities. Furthermore, certain Medicare telehealth consultations can now be conducted using audio-only technology, like telephones, for individuals unable to utilize audio and video mediums, such as smartphones or computers.
4.6.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)